You are on Trendlyne United States. Click here to go to India website or make United States as your default
person reading

About Theratechnologies Inc. - Company Information, Overview, History and Profile

What does Theratechnologies Inc. do?

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.

Theratechnologies Inc. Management structure

All Gross Remunerations are in CAD
Mr. Paul Levesque
Director, President and Chief Executive Officer
2.98 M
2024
Gross Remuneration
Year
Mr. Philippe Dubuc
Senior Vice President and Chief Financial Officer
1.02 M
2024
Gross Remuneration
Year
Mr. John Leasure
Global Commercial Officer
1.01 M
2024
Gross Remuneration
Year
Dr. Christian Marsolais, PhD
Senior Vice President and Chief Medical Officer
1.01 M
2024
Gross Remuneration
Year
Mr. Jocelyn Lafond
General Counsel and Corporate Secretary
738.31 K
2024
Gross Remuneration
Year
Ms. Marie-Noel Colussi
Vice President, Finance
-
2024
Gross Remuneration
Year

Theratechnologies Inc. Board of directors

All Gross Remunerations are in USD
Mr. Frank A. Holler
Chairman of the Board
119.66 K
2024
Gross Remuneration
Year
Ms. Dawn Svoronos
Independent Director
110.85 K
2024
Gross Remuneration
Year
Ms. Dale MacCandlish Weil
Independent Director
81.13 K
2024
Gross Remuneration
Year
Mr. Andrew T. Molson
Independent Director
76.36 K
2024
Gross Remuneration
Year
Mr. Joseph P. Arena
Independent Director
72.42 K
2024
Gross Remuneration
Year
Mr. Jordan Zwick
Independent Director
62.88 K
2024
Gross Remuneration
Year